Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPLEMENT: Pioglitazone Triglyceride Changes in T2DM
NCT00672919Phase 4Completed
- Sponsor
- Takeda
- Start
- Nov 2003
- Primary completion
- Aug 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of pioglitazone in type 2 diabetes mellitus (T2DM), dyslipidemia, sponsored by Takeda. Started Nov 2003; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)dyslipidemia
Beyond the preview
Go deeper on NCT00672919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00672919.